- Financial Market Growth and Impact Analysis of Endoscopic Vessel Harvesting Market.
According to a new market research "Endoscopic Vessel Harvesting Market by Product (EVH systems, Endoscope, Accessories), Usability (Disposable, Reusable), Vessel (Saphenous Vein, Radial Artery), Application (Coronary Artery Disease, Peripheral Artery Disease) - Global Forecast to 2022", published by MarketsandMarkets™, the global market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period.
Browse 69 tables and 31 figures spread through 113 pages and in-depth TOC on "Endoscopic Vessel Harvesting Market"
The key factors driving the growth of this market include the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. However, the availability of alternative treatment methods for CADs and poor reimbursement scenario for EVH may hinder the growth of this market to a certain extent.
By product, the EVH systems segment accounted for the largest share of the market in 2017
On the basis of product, the Endoscopic Vessel Harvesting Market is segmented into EVH systems, endoscopes, and accessories. In 2017, the EVH systems segment accounted for the largest share of the global market. The large share of this segment can be primarily attributed to the rising adoption of minimally invasive procedures for vessel harvesting and disposable nature of these products.
Download PDF Brochure@
By usability, the disposable segment held the largest market share in 2017
Based on usability, the market is segmented into disposable and reusable products. The disposable segment commanded the largest share of the Endoscopic Vessel Harvesting Market in 2017. The large share of this segment can be attributed to the rising preference for disposable devices over reusable owing to the advantages offered.
By vessel type, the saphenous vein segment held the largest market share in 2017
Based on vessel type, the market is segmented into saphenous vein and radial artery. The saphenous vein segment commanded the largest share of the Endoscopic Vessel Harvesting Market in 2017. The large share of this segment can be attributed to the significant advantages offered by the saphenous vein in terms of wound complications, reduced pain, and aesthetics.
By application, the coronary artery disease segment held the largest market share in 2017
Based on application, the market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment commanded the largest share of the Endoscopic Vessel Harvesting Market in 2017. The large share of this segment can be attributed to the rising prevalence of cardiovascular diseases and increasing geriatric population.
North America dominated the market in 2017
In 2017, North America accounted for the largest share of the Endoscopic Vessel Harvesting Industry, followed by Europe, Asia Pacific (APAC), and the Rest of the World (Latin America and the Middle East & Africa). Factors such as high burden of cardiac diseases in the US and Canada, the launch of the Hospital Readmissions Reduction Program (HRRP) and Episode-based Payment Models (EPMs) in the US, and growing preference for minimally invasive harvesting procedures in Canada are contributing to the large share of North America.
The Endoscopic Vessel Harvesting Industry in Europe is expected to witness high growth during the forecast period. This can be attributed to the rising number of CABG procedures and growth in the geriatric population in the region.
Request Sample Pages:
The key players in the global Endoscopic Vessel Harvesting Industry are Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (OTCPK:ITALY)
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.